Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: P. Wolter, C. Stefan, B. Decallonne, H. Dumez, S. Fieuws, H. Wildiers, P. Clement, D. Debaere, A. Van Oosterom, P. Schöffski
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: sunitinib, renal cell carcinoma, thyroid dysfunction, hypothyroidism, surrogate markers, progression-free survival, overall survival, tyrosine kinase inhibitor adverse effects, VEGFR inhibition, treatment efficacy prediction, hormone replacement therapy, advanced renal cell carcinoma, prognostic factors, tyrosine kinase inhibitor resistance, anti-angiogenic therapy, PDGFR
Open Access status: closed
OpenAlex ID: W2511396539
